October 2018, Volume 4, Issue 12

This issue features a look at the Right to Try debate, a breakdown of how epigenetics are used in hematology, and more.

Focus on Classical Hematology (Volume 4, Issue 12.1)

In this special edition, we take a look at the latest updates in classical hematology, from a advances in gene therapy for hemophilia to a debate about intravenous iron in pregnant women with iron-deficiency anemia, and more.

September 2018, Volume 4, Issue 11

This issue features a look at research misconduct, a debate about whether chronic lymphocytic leukemia is curable, and more.

August 2018, Volume 4, Issue 10

This issue features a look at direct-to-consumer pharmaceutical advertising, advice to graduating hematologists, and more.

July 2018 Bonus Mid-Year Edition

This bonus issue features a look at the most recent changes to Maintenance of Certification programs, highlights from recent hematology/oncology meetings, and more.

July 2018, Volume 4, Issue 8

This issue features a look at attaining gender inequality in medicine, refining patient-doctor communication, dealing with clinical trials–induced burnout, and more.

June 2018, Volume 4, Issue 7

This issue features a look at gaining oral parity for cancer medications, the unavoidable "bubbles" in which people live and work, and more.

May 2018, Volume 4, Issue 6

This issue features a look at the hidden costs of importing lower-cost drugs, the optimal hemophilia treatment, the limits of genetic testing, and more.

Focus on Myeloid Malignancies (Volume 4, Issue 6.1)

This supplement features FDA updates, clinical trials, and the latest research in myeloid malignancies.

April 2018, Volume 4, Issue 5

This issue features a look at the U.S. health-care system’s transition from a paper-based system to electronic health records, an introduction to a series about oncology nurse practitioners, and more.

Current Issue

December 2019, Volume 5, Issue 15

This issue examines the hidden costs of participating in clinical trials, explores the pediatric hematology/oncology workforce, and more.